CVS Health announced plans to drop Eli Lilly's Zepbound from its preferred coverage ... and weight loss drugs Mounjaro and Zepbound. Lilly's stock fell 11% after the Thursday announcement.

CVS Health said it will significantly expand access to Novo Nordisk's blockbuster weight loss drug Wegovy for patients ...

Eli Lilly and Company's stock dropped 11% after CVS's Zepbound exclusion, but analysts see a mispricing opportunity. Click for why LLY growth remains strong.

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed ...